Nixar 20 mg tablete
Name | Nixar 20 mg tablete |
---|---|
Marketing Authorisation Number | HR-H-535007756 |
Active Substance | bilastin |
Composition | jedna tableta sadrži 20 mg bilastina |
Pharmaceutical Form | tableta |
Packaging [MA Number for Packaging] | 10 tableta u blisteru, u kutiji [HR-H-535007756-01] 20 tableta u blisteru, u kutiji [HR-H-535007756-02] |
Manufacturer | Faes Farma S.A., Leioa (Vizcaya), Španjolska
A. Menarini Manufacturing Logistics And Services S.r.l., L'Aquila, Italija Menarini-Von Heyden GmbH, Dresden, Njemačka |
Marketing Authorisation Holder | Menarini International Operations Luxembourg S.A., 1, Avenue de la Gare, Luksemburg, Luksemburg |
Marketing Authorisation Date | 12.01.2018 |
MA Period of Validity | unlimited |
Classification Number | UP/I-530-09/16-02/515 |
Registration Number | 381-12-01/30-18-04 |
Prescription | na recept |
Type of prescription | ponovljivi recept |
Distribution | u ljekarni |
Advertising to general public | zabranjeno |
ATC Code | R06AX29 |
Medicinal product marketed in the Croatia | Da |
SmPC | download |
PL | download |
Summary of risk management plan | download |